160 related articles for article (PubMed ID: 22311742)
1. Flow cytometry in cancer stem cell analysis and separation.
Greve B; Kelsch R; Spaniol K; Eich HT; Götte M
Cytometry A; 2012 Apr; 81(4):284-93. PubMed ID: 22311742
[TBL] [Abstract][Full Text] [Related]
2. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
[TBL] [Abstract][Full Text] [Related]
3. Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells.
Khan MI; Czarnecka AM; Helbrecht I; Bartnik E; Lian F; Szczylik C
Stem Cell Res Ther; 2015 Sep; 6(1):178. PubMed ID: 26377541
[TBL] [Abstract][Full Text] [Related]
4. Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity.
Zhang G; Ma L; Xie YK; Miao XB; Jin C
Mol Med Rep; 2012 Sep; 6(3):519-24. PubMed ID: 22684859
[TBL] [Abstract][Full Text] [Related]
5. ALDH Activity Assay: A Method for Cancer Stem Cell (CSC) Identification and Isolation.
Del Vecchio V; La Noce M; Tirino V
Methods Mol Biol; 2024; 2777():83-89. PubMed ID: 38478337
[TBL] [Abstract][Full Text] [Related]
6. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis.
Marcato P; Dean CA; Pan D; Araslanova R; Gillis M; Joshi M; Helyer L; Pan L; Leidal A; Gujar S; Giacomantonio CA; Lee PW
Stem Cells; 2011 Jan; 29(1):32-45. PubMed ID: 21280157
[TBL] [Abstract][Full Text] [Related]
8. Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.
Pierre-Louis O; Clay D; Brunet de la Grange P; Blazsek I; Desterke C; Guerton B; Blondeau C; Malfuson JV; Prat M; Bennaceur-Griscelli A; Lataillade JJ; Le Bousse-Kerdilès MC
Stem Cells; 2009 Oct; 27(10):2552-62. PubMed ID: 19650038
[TBL] [Abstract][Full Text] [Related]
9. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.
Ma S; Chan KW; Lee TK; Tang KH; Wo JY; Zheng BJ; Guan XY
Mol Cancer Res; 2008 Jul; 6(7):1146-53. PubMed ID: 18644979
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric techniques for detection of candidate cancer stem cell subpopulations in canine tumour models.
Blacking TM; Waterfall M; Samuel K; Argyle DJ
Vet Comp Oncol; 2012 Dec; 10(4):252-73. PubMed ID: 22236076
[TBL] [Abstract][Full Text] [Related]
11. The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance.
Januchowski R; Wojtowicz K; Zabel M
Biomed Pharmacother; 2013 Sep; 67(7):669-80. PubMed ID: 23721823
[TBL] [Abstract][Full Text] [Related]
12. Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes.
Allen JE; Hart LS; Dicker DT; Wang W; El-Deiry WS
Cancer Biol Ther; 2009 Nov; 8(22):2194-205. PubMed ID: 19923899
[TBL] [Abstract][Full Text] [Related]
13. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Farnie G; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
[TBL] [Abstract][Full Text] [Related]
14. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
Wang L; Park P; La Marca F; Than KD; Lin CY
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
[TBL] [Abstract][Full Text] [Related]
15. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential.
Hiraga T; Ito S; Nakamura H
Oncol Rep; 2011 Jan; 25(1):289-96. PubMed ID: 21109989
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell characteristics in retinoblastoma.
Seigel GM; Campbell LM; Narayan M; Gonzalez-Fernandez F
Mol Vis; 2005 Sep; 11():729-37. PubMed ID: 16179903
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Lin⁻ALDH (bright) population using Ehrlich ascites tumor cells in mice.
Yalçintepe L; Altinel P; Albeniz I; Yilmaz A; Nurten R
Tumour Biol; 2014 Oct; 35(10):10363-73. PubMed ID: 25048967
[TBL] [Abstract][Full Text] [Related]
18. Methods for cancer stem cell detection and isolation.
Tirino V; Desiderio V; Paino F; Papaccio G; De Rosa M
Methods Mol Biol; 2012; 879():513-29. PubMed ID: 22610581
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicine-mediated cancer stem cell therapy.
Shen S; Xia JX; Wang J
Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
[TBL] [Abstract][Full Text] [Related]
20. Requirement of ABC transporter inhibition and Hoechst 33342 dye deprivation for the assessment of side population-defined C6 glioma stem cell metabolism using fluorescent probes.
Murota Y; Tabu K; Taga T
BMC Cancer; 2016 Nov; 16(1):847. PubMed ID: 27814696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
